3.1 | Patient demographics
Since the onset of the pre-transplant RVI screening program at our institution, 161 patients received allogeneic HSCT who were eligible to be included in the study based on viral PCR testing. Patients age ranged from 0.3 to 28.6 years, with the average being 9.7 years. 66 patients were female and 95 patients were male. Table 1 outlines indications for transplant, use of T cell depletion, conditioning intensity, use of serotherapy, stem cell source, HLA mismatch, and CMV concordance.